Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 1 Recurrence 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Cholangiocarcinoma 1

Interventions

Gemcitabine 13 Oxaliplatin 9 Capecitabine 6 lenvatinib 5 apatinib 5 Cisplatin 5 tislelizumab 4 Surgical Procedures, Operative 4 Radiofrequency Ablation 4 Neoadjuvant Therapy 4 Fluorouracil 4 toripalimab 3 sintilimab 3 Radiotherapy 3 Leucovorin 3 Irinotecan 3 regorafenib 2 pembrolizumab 2 durvalumab 2 camrelizumab 2 Stents 2 Photochemotherapy 2 Immunotherapy 2 Hepatectomy 2 Folfox protocol 2 Everolimus 2 Drug Therapy 2 Cholangiopancreatography, Endoscopic Retrograde 2 Blood Specimen Collection 2 1-phenyl-3,3-dimethyltriazene 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cholangiocarcinoma × Yttrium-90 × Clear all

NCT06375915 2024-05-24

PM-CARE

IRCCS San Raffaele

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡